Immunology of COVID-19 and disease-modifying therapies: The good, the bad and the unknown.
Tobias ZrzavyIsabella WimmerPaulus Stefan RommerThomas BergerPublished in: European journal of neurology (2020)
Despite the knowledge gain over the last few months, current evidence remains limited, and, thus, further clinical vigilance and systematic documentation is essential.